China SXT Pharmaceuticals (SXTC) Finished Goods (2021 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Finished Goods of $639602.0 for Q1 2026, up 42.56% year-over-year from $448668.0 in Q1 2025, and up 25.09% quarter-over-quarter from $511307.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Finished Goods (2021 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Finished Goods history runs 6 years deep, the most recent figure standing at $639602.0 for Q1 2026.
- In Q1 2026, Finished Goods rose 42.56% year-over-year to $639602.0; the TTM figure through Mar 2026 stood at $639602.0 (up 42.56% YoY), while the FY2026 annual figure was $639602.0, up 42.56% from the prior year.
- Finished Goods for Q1 2026 stood at $639602.0, up from $511307.0 in the prior quarter.
- The five-year high for Finished Goods was $639602.0 in Q1 2026, with the low at $446866.0 in Q1 2023.
- The 5-year median for Finished Goods is $569214.5 (2022), against an average of $546743.8.
- The sharpest annual moves came in 2023 and 2026: Finished Goods retreated 23.58% in 2023, then jumped 42.56% in 2026.
- China SXT Pharmaceuticals' Finished Goods stood at $588827.0 in 2022, then fell by 24.11% to $446866.0 in 2023, then jumped by 34.32% to $600251.0 in 2024, then slipped by 14.82% to $511307.0 in 2025, then grew by 25.09% to $639602.0 in 2026.
- Business Quant data shows SXTC's Finished Goods at $639602.0 in Q1 2026, $511307.0 in Q3 2025, and $448668.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | China SXT Pharmaceuticals | 32,029.07 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 639,602.00 |
| Sep 30, 2025 | 511,307.00 |
| Mar 31, 2025 | 448,668.00 |
| Sep 30, 2024 | 600,251.00 |
| Mar 31, 2024 | 553,682.00 |
| Mar 31, 2023 | 446,866.00 |
| Sep 30, 2022 | 588,827.00 |
| Mar 31, 2022 | 584,747.00 |
| Sep 30, 2021 | 618,347.00 |
| Mar 31, 2021 | 620,736.00 |